216 related articles for article (PubMed ID: 22528555)
1. Baroreflex activation for the treatment of heart failure.
Sabbah HN
Curr Cardiol Rep; 2012 Jun; 14(3):326-33. PubMed ID: 22528555
[TBL] [Abstract][Full Text] [Related]
2. Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure.
Sabbah HN; Gupta RC; Imai M; Irwin ED; Rastogi S; Rossing MA; Kieval RS
Circ Heart Fail; 2011 Jan; 4(1):65-70. PubMed ID: 21097604
[TBL] [Abstract][Full Text] [Related]
3. Vagus nerve stimulation in experimental heart failure.
Sabbah HN; Ilsar I; Zaretsky A; Rastogi S; Wang M; Gupta RC
Heart Fail Rev; 2011 Mar; 16(2):171-8. PubMed ID: 21128115
[TBL] [Abstract][Full Text] [Related]
4. Electrical vagus nerve stimulation for the treatment of chronic heart failure.
Sabbah HN
Cleve Clin J Med; 2011 Aug; 78 Suppl 1(0 1):S24-9. PubMed ID: 21972326
[TBL] [Abstract][Full Text] [Related]
5. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
[TBL] [Abstract][Full Text] [Related]
6. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.
Gronda E; Seravalle G; Brambilla G; Costantino G; Casini A; Alsheraei A; Lovett EG; Mancia G; Grassi G
Eur J Heart Fail; 2014 Sep; 16(9):977-83. PubMed ID: 25067799
[TBL] [Abstract][Full Text] [Related]
7. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN
J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662
[TBL] [Abstract][Full Text] [Related]
8. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
[TBL] [Abstract][Full Text] [Related]
9. Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.
Dell'Oro R; Gronda E; Seravalle G; Costantino G; Alberti L; Baronio B; Staine T; Vanoli E; Mancia G; Grassi G
J Hypertens; 2017 Dec; 35(12):2532-2536. PubMed ID: 28816745
[TBL] [Abstract][Full Text] [Related]
10. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
[TBL] [Abstract][Full Text] [Related]
11. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
Mann JA; Abraham WT
Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
[TBL] [Abstract][Full Text] [Related]
13. Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States.
Bisognano J; Schneider JE; Davies S; Ohsfeldt RL; Galle E; Stojanovic I; Deering TF; Lindenfeld J; Zile MR
BMC Cardiovasc Disord; 2021 Mar; 21(1):155. PubMed ID: 33771104
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary Baroreflex Control of Renal Sympathetic Nerve Activity Is Impaired in Dogs With Left Ventricular Dysfunction.
Dunlap ME; Kinugawa T; Sica DA; Thames MD
J Card Fail; 2019 Oct; 25(10):819-827. PubMed ID: 31449963
[TBL] [Abstract][Full Text] [Related]
15. Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single-centre experience.
Blanco C; Madej T; Mangner N; Hommel J; Grimm S; Knaut M; Linke A; Winzer EB
ESC Heart Fail; 2023 Dec; 10(6):3373-3384. PubMed ID: 37667319
[TBL] [Abstract][Full Text] [Related]
16. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
Weaver FA; Abraham WT; Little WC; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Madershahian N; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Zile MR
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):320-328. PubMed ID: 28043438
[TBL] [Abstract][Full Text] [Related]
17. Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights.
Grassi G; Brambilla G; Pizzalla DP; Seravalle G
Curr Hypertens Rep; 2016 Aug; 18(8):60. PubMed ID: 27334011
[TBL] [Abstract][Full Text] [Related]
18. Autonomic Modulation With Baroreflex Activation Therapy in Heart Failure.
Gronda E; Vanoli E
Curr Heart Fail Rep; 2016 Dec; 13(6):273-280. PubMed ID: 27854009
[TBL] [Abstract][Full Text] [Related]
19. The cellular and physiologic effects of beta blockers in heart failure.
Sabbah HN
Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
[TBL] [Abstract][Full Text] [Related]
20. [Baroreflex ActivationTherapy for Heart Failure].
Xu Y; Yang YJ; Guo J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):717-721. PubMed ID: 36065707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
